CALC
Price:
$4.57
Market Cap:
$65.85M
CalciMedica, Inc., a clinical-stage biotechnology company, focuses on developing therapies for life-threatening inflammatory diseases with unmet needs. Its proprietary technology targets the inhibition of calcium release-activated (CRAC) channels designs to modulate the immune response and protect against tissue cell injury in life-threatening inflammatory diseases. Its lead product candidate is Auxora, a proprietary intravenous-formulated CRAC channel inhibitor for the treatment of acute pancreatitis, asparaginase-associated acute pancreatitis, and acute kidney injury. The company is based in La Jolla, California.
Industry
Biotechnology
IPO Date
2023-06-14
Stock Exchange
NASDAQ
Ticker
CALC
According to CalciMedica, Inc.’s latest financial reports and current stock price. The company's current PE Ratio is -2.82. This represents a change of -99.24% compared to the average of -373.14 of the last 4 quarters.
The mean historical PE Ratio of CalciMedica, Inc. over the last ten years is -0.60. The current -2.82 PE Ratio has changed 46.70% with respect to the historical average. Over the past ten years (40 quarters), CALC's PE Ratio was at its highest in in the March 2024 quarter at 73.72. The PE Ratio was at its lowest in in the September 2025 quarter at -1487.55.
Average
-0.60
Median
-0.25
Minimum
-2.91
Maximum
-0.10
Discovering the peaks and valleys of CalciMedica, Inc. PE Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 677.46%
Maximum Annual PE Ratio = -0.10
Minimum Annual Increase = -38.44%
Minimum Annual PE Ratio = -2.91
| Year | PE Ratio | Change |
|---|---|---|
| 2024 | -2.91 | 677.46% |
| 2023 | -0.37 | 48.46% |
| 2022 | -0.25 | 1.98% |
| 2021 | -0.25 | 146.18% |
| 2020 | -0.10 | -38.44% |
| 2019 | -0.16 | -7.67% |
The current PE Ratio of CalciMedica, Inc. (CALC) is less than than its 3-year, less than than its 5-year, and less than than its 10-year historical averages
3-year avg
-1.18
5-year avg
-0.78
10-year avg
-0.60
CalciMedica, Inc.’s PE Ratio is less than Tvardi Therapeutics, Inc. (-2.81), less than Lantern Pharma Inc. (-2.11), less than LAVA Therapeutics N.V. (-1.65), less than Actinium Pharmaceuticals, Inc. (-1.31), less than Elutia Inc. (-1.07), less than Reviva Pharmaceuticals Holdings, Inc. (-1.09), less than Xilio Therapeutics, Inc. (-2.53), less than PDS Biotechnology Corporation (-1.20), less than MAIA Biotechnology, Inc. (-2.25), greater than RenovoRx, Inc. (-3.26),
| Company | PE Ratio | Market cap |
|---|---|---|
| -2.81 | $39.21M | |
| -2.11 | $42.17M | |
| -1.65 | $45.77M | |
| -1.31 | $45.23M | |
| -1.07 | $29.45M | |
| -1.09 | $40.31M | |
| -2.53 | $38.90M | |
| -1.20 | $43.78M | |
| -2.25 | $44.44M | |
| -3.26 | $34.82M |
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like CalciMedica, Inc. using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
The easiest way to analyze a company like CalciMedica, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
What is the PE Ratio?
How can you use the PE Ratio?
What is CalciMedica, Inc.'s PE Ratio?
How is the PE Ratio calculated for CalciMedica, Inc. (CALC)?
What is the highest PE Ratio for CalciMedica, Inc. (CALC)?
What is the 3-year average PE Ratio for CalciMedica, Inc. (CALC)?
What is the 5-year average PE Ratio for CalciMedica, Inc. (CALC)?
How does the current PE Ratio for CalciMedica, Inc. (CALC) compare to its historical average?